A bioinformatics analysis of pairing 64 drugs used to treat breast cancer has allowed researchers to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.
A bioinformatics analysis of pairing 64 drugs used to treat breast cancer has allowed researchers to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.